Clinical Trial

Predicting Response to Naltrexone With Eye Tracking in Gaming Disorder

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
It is a double blind controlled study to test the hypothesis that it's possible to predict the response to naltrexone in Videogame Disorder with the use of Eye Tracking device, during a period of 12 weeks
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-11-24; most recent amendment 2026-07-23.
Status change: Not Yet Recruiting → Recruiting 2026-07-20
Trial Details
NCT Number NCT04649892
Lead Sponsor University of Sao Paulo
Conditions Gaming Disorder
Enrollment 40 participants
Start Date 2026-07-01
Primary Completion 2026-12 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-27